Overcoming recurrence: How research is bringing new hope for breast cancer patients – The Institute of Cancer Research
The Institute of Cancer Research shared on LinkedIn:
“One in five women with breast cancer will see the disease return years or even decades after successful treatment.
Living with this risk places a significant psychological burden on many survivors. Our researchers are making huge strides towards decreasing recurrence rates, exploring different treatment avenues.
One team has developed a computational tool that could help scientists boost each patient’s immune response to breast cancer that has spread, maximising treatment effectiveness.
Another has found a way to eliminate the ‘dormant’ breast cancer cells that can persist in the body following treatment and cause the disease to return at a later date.
Future treatments that use this approach could remove the worry of recurrence. In complementary work, our researchers have also developed a technique that makes it possible to predict breast cancer recurrence months or even years ahead of it occurring, giving clinicians a large window to intervene.
Read our latest blog post to find out more about our ground-breaking work in this area.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023